EXAS — Exact Sciences Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapFalling Star

Annual cashflow statement for Exact Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	C2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-84	-849	-596	-624	-204
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	161	874	455	241	155
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-53.6	-42.7	111	-26.4	-0.342
Change in Accounts Receivable
Change in Inventories
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities	-112	136	-102	-224	156
Capital Expenditures	-173	-476	-194	-214	-125
Purchase of Fixed Assets
Software Development Costs
Other Investing Cash Flow Items	48.2	-226	-888	289	174
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-124	-702	-1,082	74.1	49.7
Financing Cash Flow Items	7.95	15.3	17.8	20	18.6
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	253	1,880	8.47	76.5	160
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	17.1	1,314	-1,176	-73	367